We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Every year, West without Borders, the global employee-led program at West, chooses a charity to support, demonstrating the company's commitment to giving back. In 2023, the program selected the Michael J. Fox Foundation (MJFF) as its charity of choice. The decision was met with enthusiasm from team members across West's global headquarters and beyond.
Throughout three impactful weeks in May, team members rallied together, showcasing their generosity and compassion. Their collective efforts resulted in a generous donation of over $150,000, which was matched by the Herman O West Foundation. They raised over $300,000. in support of MJFF's mission to accelerate the next generation of Parkinson's disease treatments.
The Michael J. Fox Foundation is dedicated to driving progress in Parkinson's research, aiming to improve the lives of those affected by this challenging disease. By funding crucial projects and addressing field-wide obstacles, MJFF plays a pivotal role in advancing scientific knowledge and enhancing patient care.
At West, the campaign to support MJFF was more than just a fundraising initiative; it was a deeply personal endeavor. Team members shared touching stories and experiences, highlighting their connections to Parkinson's disease and their gratitude for the opportunity to make a difference. Jay Stephens, Charles Witherspoon, and Caitlin Joran , among others, expressed their appreciation for being able to contribute to to a cause that holds special significance for them.
The program's success was a testament to the dedication and unity of West's employees across various locations, including Exton, Radnor, Eagleview, and Upper Darby. Together, they demonstrated the power of collective action, showcasing the impact that can be achieved when individuals come together for a common cause.
West's commitment to philanthropy did not go unnoticed. The company was recognized at the MJFF MVP event for being a top 10 fundraiser of 2023. Team members Jay and Caitlin along with Caitlin’s mom, represented West with pride. Their participation in the event symbolized the meaningful partnership between West and MJFF, highlighting the importance of collaboration in driving positive change.
As the campaign concluded, Jay and Caitlin reflected on the significance of their involvement and why it resonated deeply with them.
Jay’s Perspective:
I am deeply grateful for all the support West has provided through the West without Borders Campaign raising funds to benefit Parkinson’s research. My best friend’s father was diagnosed 15 years ago and, at first, I did know not much about this disease and the impact it would have on him. So, I did what anyone in my position would do; I googled what Parkinson’s was. I learned very quickly how serious such a diagnosis was and that no cure was available. In an effort to help my best friend’s father’s situation, he started a golf outing titled “Putt for Parkinson’s” in 2012. That year we started with 12 golfers and raised a little over a thousand dollars which was fully donated to MJFF. Over time, the event grow with more golfers, partners and sponsorships continuing to raise additional money each year to fund the incredible research at MJFF. In 2022, West was gracious enough to be our title sponsor (and still to this day) and helped elevate the event which now includes 400 golfers annually and total over fifty thousand dollars in donations to MJFF each year. Unfortunately, in 2023 we lost “Big Lou” as his battle with Parkinson’s came to an end but the fight to find a cure continues on. Words cannot express the tirelessly efforts for advocates, like myself, Caitlin and West, to raise awareness and contribute to our mission of finding a cure for this disease. West unwavering dedication and generosity help make tremendous impacts to various charities, like MJFF, to fund critical research and support innovative treatments. I am deeply proud to work at West and to be a member of this incredible community. It is truly inspiring to witness the culture and employees rally around a cause, supporting not only the mission but also each other. I am forever grateful for the steadfast support of West and the profound impact their philanthropic work has on the lives of those affected by this disease. Thank you for standing with me and making a difference in this vital journey.
Caitlin’s Perspective:
The support West provides to Parkinsons research and fundraising means a lot to me because I have watched my mom battle this disease for over 18 years. She is my hero. She wakes up every day and takes this disease in stride. The work the Micheal J. Fox foundation does to support research for finding a cause and cure for this disease is so important. When she was first diagnosed, we took a vacation as a family thinking it would be the last. The constant need for new and improved treatments is essential for quality of life. Although medications help with treatment of the symptoms, the challenge is finding the cause and cure for this disease. There is nothing to prevent it, pause it or cure it, which is why fundraising efforts like this are so important. The more I walk her journey with her the more Parkinson’s is found throughout my life. My best friend’s father was diagnosed with Parkinson’s and lost his battle, I have two uncles recently diagnosed (non-blood related) with this disease and I hear more and more people say “oh I know someone with Parkinson’s” the more I share my story. My family started a walk (The Avalon Flip-Flop Walk for a Cure for Parkinson’s) 15 years ago to support local funding and research through the Parkinsons council in Philadelphia, West also sponsors that walk for the past 10 years and I am beyond thankful for their support. Through the constant efforts of charities like Michael J Fox Foundation and the Parkinson’s Council, my mom has been able to continue to walk, talk, swallow and function which is not always the case with this disease. A statement on the wall at the Michael J Fox Foundation Award Ceremony was “Here, until Parkinson’s isn’t” and seeing the research and strides that these charities are making gives us hope that one day there will be a cure or at least a means to pause the disease in its tracks.
Their heartfelt testimonials emphasized the personal connections and sense of fulfillment derived from supporting MJFF's vital mission. In recognition of their outstanding efforts, West was celebrated as one of MJFF's top ten teams, further solidifying the company's commitment to making a difference in the lives of others. The journey to support MJFF was more than a fundraising endeavor; it was a testament to West's values of compassion, unity, and empowerment.
Through West Without Borders, employees continue to inspire and uplift communities, embodying the spirit of philanthropy and collective action. As West looks towards the future, the company remains steadfast in its dedication to creating positive change and transforming lives, one charitable initiative at a time.
West without Borders is not affiliated with Doctors Without Borders®, which is a registered service mark of Bureau International de Médecins San Frontières.
Drug delivery via cartridge-based systems has been around for many years, with traditional applications being for the dental and insulin markets. These traditional markets will continue to maintain much of the volume for cartridge-based systems in the future; however, there is an increasing trend toward other therapeutic classes of drugs, such as those that treat auto-immune diseases, that never used cartridges before. This trend, along with the projected growth in the insulin market, indicates substantial overall growth in the cartridge space over the next several years. This Blog discusses the issues driving these trends and the West product portfolio in the cartridge market.
Container closure integrity (CCI) is a fundamental requirement of every sterile drug package. Recently, the United States Pharmacopeia Convention (USP) published a guidance in this area that, among other key topics, addresses test methods in detail: Chapter <1207> Package Integrity Evaluation – Sterile Products. However, proper test method is only one aspect of achieving good CCI.
The rise in type 2 diabetes has sparked a variety of treatment options, including glucagon-like peptide-1 (GLP-1) receptor agonists. GLP-1s are a class of injected drugs (additional oral options are currently in development) that “mimic the action of GLP-1 and increase the incretin effect in patients with type 2 diabetes, stimulating the release of insulin.”<sup>1</sup> Commonly used when oral treatment alone is not enough, the benefits of GLP-1s include a reduction of glucagon and glycosylated haemoglobin (HbA1c), weight loss and a low risk of hypoglycemia.<sup>2</sup>
Advanced therapies are rapidly becoming a reality, targeting unmet patient needs and treatments for diseases with limited therapeutic options. Some advanced therapies, such as gene therapy and mRNA, require frozen storage due to their fragile nature at ambient temperature, putting unprecedented expectations on the vial-stopper-seal combination to maintain container closure integrity (CCI) during storage at low temperature conditions. The quality, patient safety, and high value of these therapeutics can be jeopardized if the chosen vial-stopper-seal combination doesn’t maintain a sterile barrier from when the drug is packaged through to administration to the patient. During cooling from ambient temperature to temperatures below -80°C, packaging components such as glass vials, elastomeric closures, and aluminum seals exhibit contraction and changes in physico-mechanical properties. These changes in material properties and component dimensions may affect their ability to maintain CCI, resulting in the formation of transient leaks.
One of the challenges a drug manufacturer faces is controlling the drug product at the point-of-use in a hospital or clinical environment. Often the method of vial access is variable, leading to an increased risk of harmful patient outcomes such as stopper cores or fragments entering into the drug product, which can contribute to cardiovascular events. There are a number of causes that contribute to stopper coring and fragmentation in the field that depend primarily on the technique of the practitioner and the properties of the elastomeric closure.
English
Chinese
